» Articles » PMID: 21412590

Neurobrucellosis: Clinical, Diagnostic, Therapeutic Features and Outcome. Unusual Clinical Presentations in an Endemic Region

Overview
Date 2011 Mar 18
PMID 21412590
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Brucellosis is a zoonotic infection and has endemic characteristics. Neurobrucellosis is an uncommon complication of this infection. The aim of this study was to present unusual clinical manifestations and to discuss the management and outcome of a series of 18 neurobrucellosis cases. Initial clinical manifestations consist of pseudotumor cerebri in one case, white matter lesions and demyelinating syndrome in three cases, intracranial granuloma in one case, transverse myelitis in two cases, sagittal sinus thrombosis in one case, spinal arachnoiditis in one case, intracranial vasculitis in one case, in addition to meningitis in all cases. Eleven patients were male and seven were female. The most prevalent symptoms were headache (83%) and fever (44%). All patients were treated with rifampicin, doxycycline plus trimethoprim-sulfamethoxazole or ceftriaxone. Duration of treatment (varied 3-12 months) was determined on basis of the CSF response. In four patients presented with left mild sequelae including aphasia, hearing loss, hemiparesis. In conclusion, although mortality is rare in neurobrucellosis, its sequelae are significant. In neurobrucellosis various clinical and neuroradiologic signs and symptoms can be confused with other neurologic diseases. In inhabitants or visitors of endemic areas, neurobrucellosis should be kept in mind in cases that have unusual neurological manifestations.

Citing Articles

Neurobrucellosis: a retrospective cohort of 106 patients.

Arazi F, Haddad M, Sheybani F, Farzadfard M, Rezaeian M Trop Med Health. 2025; 53(1):9.

PMID: 39815371 PMC: 11737133. DOI: 10.1186/s41182-025-00680-1.


The research trend on neurobrucellosis over the past 30 years (1993-2023): a bibliometric and visualization analysis.

Yang L, Pan W, Cai Q, An M, Wang C, Pan X Front Neurol. 2024; 15:1349530.

PMID: 39381075 PMC: 11460295. DOI: 10.3389/fneur.2024.1349530.


Brucellosis infection complicated with myelitis: a case report and literature review.

Ma X, Wang Y, Wu Q, Ma X, Wang Q, Guo Q Front Cell Infect Microbiol. 2024; 14:1378331.

PMID: 38817447 PMC: 11137236. DOI: 10.3389/fcimb.2024.1378331.


Neurobrucellosis: laboratory features, clinical characteristics, antibiotic treatment, and clinical outcomes of 21 patients.

Zhuang W, He T, Tuerheng J, He G, Wang B, Yang Y BMC Infect Dis. 2024; 24(1):485.

PMID: 38730327 PMC: 11088156. DOI: 10.1186/s12879-024-09308-x.


Metagenomic next-generation sequencing for the diagnosis of neurobrucellosis.

Li W, He Y, Li Y, Li X, Bian T, Liu T Future Microbiol. 2024; 19(6):509-518.

PMID: 38629898 PMC: 11216504. DOI: 10.2217/fmb-2023-0177.